As a child who grew up in Ado-Ekiti, Nigeria, I suffered from multiple episodes of malaria infection. This first-hand experience sparked my interest to understand the mechanism of infectious disease development and progression, which led me to study Biochemistry as an undergraduate. Subsequently, during my master's program at Covenant University, my research explored the possibility of identifying new therapeutic approaches to tackle malaria by disrupting the gene regulatory mechanism of malaria parasites. The findings from this study and the alarming rate of malaria mortality further strengthened my resolve to address this challenge. At Cambridge, I will join the Merrick Group to explore the novel field of histone lactylation and its impact on the virulence of malaria parasites. I am excited about the potential this work holds for developing better antimalarial therapies with low propensity for resistance. I feel deeply honoured to have joined the Gates community, and I look forward to an enriching experience of growth and global impact.
EKITI STATE UNIVERSITY BIOCHEMISTRY
COVENANT UNIVERSITY BIOCHEMISTRY